在永久心脏起器插入后发生的中血瘤.
Ashishpreet Singh1, Navdeep Singh Dhillon1, Suraj Kumar1
1Cardiology, All India Institute of Medical Sciences Bathinda, Bathinda, Punjab, India.
BMJ case reports
|June 13, 2025
概括
中血瘤是永久起器插入 (PPI) 后的罕见并发症. 这种静脉损伤的保守管理导致患者的症状改善和血液瘤解决.
科学领域:
- 心脏病学 心脏病学
- 医疗并发症 医疗并发症
- 手术病例报告 手术病例报告
背景情况:
- 中血瘤是永久起器插入 (PPI) 后的一种罕见但严重的并发症.
- 在PPI期间的阳性静脉损伤可能导致中血瘤的形成.
- 迅速识别和管理对于有利的结果至关重要.
研究的目的:
- 报告在永久心脏起器插入后发生的中血瘤病例.
- 为了强调对这种并发症的保守管理的重要性.
- 强调早期检测和干预的临床警.
主要方法:
- 一个60多岁的女性心脏完全受阻的病例报告.
- 经过放射学检查证实了中血瘤的诊断.
- 对于患者而言,采用保守的管理方法.
主要成果:
- 患者在PPI后出现了呼吸困难,这归因于大型的中血瘤.
- 保守的管理导致症状逐渐改善.
- 放射学后续检查证实了中膜血瘤的消失.
结论:
- 在PPI后,可能是由于静脉损伤引起的中血瘤,可以在良好的预后的情况下保守地管理.
- 对这种罕见的并发症保持警对于及时干预至关重要.
- 这一案例强调了迅速识别和保守治疗的有效性.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


